Project Inform
   
health info  ::  hiv treatment  ::  p.i. perspective  ::  #36

PI Perspective #36

October 2003     View PDF     En español

New Anti-HIV Drugs Receive FDA Approval

Three anti-HIV drugs have recently been approved by the Food and Drug Administration, including one in a new class called fusion or entry inhibitor. Each adds something unique to the arsenal of therapies to treat HIV infection. The three include:

Drug Name

Trade Name

Company

Drug Class

  T20, enfuvirtide

Fuzeon

Hoffman La-Roche, Trimeris

entry inhibitor

  FTC, emtricitabine

Emtriva

Gilead

nucleoside analog reverse transcriptase inhibitor

  Atazanavir

Reyataz

Bristol Meyers Squibb

protease inhibitor

The Cure: We Get What We Demand

LAST      NEXT

Fuzeon
 
     
 

© 2008 Project Inform  1375 Mission Street,  San Francisco, CA 94103  415-558-8669
National HIV/AIDS Treatment Hotline 1-800-822-7422 (415-558-9051 local/int'l) 10a-4p Mon-Fri PST